Shortcuts from other journals

New treatment for sepsis disappointing in children

BMJ 2007; 334 doi: 10.1136/bmj.39156.609271.80 (Published 22 March 2007)
Cite this as: BMJ 2007;334:608.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Drotrecogin alfa, a recombinant human activated protein C, is a new treatment for severe sepsis. At least one trial has shown that it reduces mortality in adults, so researchers were “profoundly disappointed” to find that it may not work so well, if at …

Access to the full text of this article requires a subscription or payment

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

THIS WEEK'S POLL